Aldurazyme and hydrocephalus Patient Reports February 12, 2012

Aldurazyme Side Effects Report #4632620-3
Aldurazyme side effect was reported by a Physician from on Mar 16, 2005. Female patient was diagnosed with mucopolysaccharidosis ih and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: anaemia, hydrocephalus . Aldurazyme dosage: unknown. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5442936-9
Aldurazyme side effect was reported by a Physician from SPAIN on Aug 16, 2007. Female patient, child 6 years of age, weighting 36.60 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: hydrocephalus , intracranial pressure increased, visual acuity reduced. Aldurazyme dosage: unknown. During the same period patient was treated with ERYTHROMYCIN, FLUTICASONE PROPIONATE. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #6081440-4
Aldurazyme side effect was reported by a Physician from UNITED STATES on Feb 05, 2009. Female patient, child 6 years of age, weighting 40.12 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: asthenia, bradycardia, cardio-respiratory arrest, catheter related complication, cough, dyspnoea, hydrocephalus , hypoxia, infusion site oedema. Aldurazyme dosage: 8.7 MG, 1X/W, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHNE, HEPARIN. Patient died.

Aldurazyme Side Effects Report #5762050-2
Aldurazyme side effect was reported by a Physician from COLOMBIA on May 20, 2008. Female patient, child 3 years of age, weighting 26.46 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: cyanosis, headache , hydrocephalus , infusion related reaction, oxygen saturation decreased, pneumonia , tachypnoea, vomiting. Aldurazyme dosage: 0.5 MG/KG, INTRAVENOUS. During the same period patient was treated with BECLOMETHASONE DIPROPIONATE, SALBUTAMOL, NIFEDIPINE, RANITIDINE, FUROSEMIDE, IPRATROPIUM BROMIDE. Patient was hospitalized. Patient recovered.


Aldurazyme Side Effects Report #4971734-5
Aldurazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2006. Female patient, child 3 years of age, weighting 29.10 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: catheter related complication, crying, hydrocephalus , pneumonia . Aldurazyme dosage: 8.7 MG QWK IV. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #4971736-9
Aldurazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2006. Female patient, child 3 years of age, weighting 29.10 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: acidosis, catheter related complication, central nervous system infection, cyanosis, device occlusion, heart rate increased, hydrocephalus , hyperglycaemia, pneumonia . Aldurazyme dosage: 8.7 MG QWK IV. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #6058007-7
Aldurazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 16, 2009. Male patient, 16 years of age, weighting 125.2 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: cardiac valve disease, catheter sepsis, hydrocephalus , poor venous access. Aldurazyme dosage: 31.9 MG, 1X/W, UNK. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5390720-7
Aldurazyme side effect was reported by a Physician from CANADA on Nov 07, 2006. Male patient, weighting 39.68 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: bone marrow transplant , cardiac valve disease, condition aggravated, deafness, hydrocephalus , kyphoscoliosis. Aldurazyme dosage: unknown. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5390721-9
Aldurazyme side effect was reported by a Physician from CANADA on May 30, 2006. Male patient, weighting 39.68 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: cardiac valve disease, condition aggravated, deafness, hydrocephalus , kyphoscoliosis. Aldurazyme dosage: unknown. Patient was hospitalized. Patient recovered.


Aldurazyme Side Effects Report #4680237-7
Aldurazyme side effect was reported by a Health Professional from on May 17, 2005. Female patient, weighting 68.78 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, hydrocephalus . Aldurazyme dosage: 8.7 MG QWK IV. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #4707219-0
Aldurazyme side effect was reported by a Health Professional from on June 14, 2005. Female patient, weighting 68.78 lb, was diagnosed with mucopolysaccharidosis i and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, hydrocephalus . Aldurazyme dosage: 8.7 MG QWK IV. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #6071856-4
Aldurazyme side effect was reported by a Health Professional from UNITED STATES on Jan 23, 2009. Female patient, child 6 years of age, weighting 30.42 lb, was diagnosed with mucopolysaccharidosis and was treated with Aldurazyme. After drug was administered, patient experienced the following side effects: asthenia, catheter related complication, catheter site swelling, dyspnoea, hydrocephalus , hypoxia, pneumonia , respiratory arrest, respiratory distress. Aldurazyme dosage: 8.6 MG, 1X/W, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN, HEPARIN. Patient died.